Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACCENTURE PLC (ACN)

  • Business News
  • June 02, 2026, 10:59 UTC
  • 3
  • 1 comments

Accenture to Announce Third-Quarter Fiscal 2026 Results

Market reaction Comment Full text

FURY GOLD MINES LTD (FURY)

  • Business News
  • June 02, 2026, 10:59 UTC
  • 5
  • 1 comments

Fury Reports 7.86 g/t Gold Over 9.43 Metres in Infill Drilling at the Eau Claire Gold Project, Quebec

Market reaction Comment Full text

BOWMAN CONSULTING GROUP LTD. (BWMN)

  • Business News
  • June 02, 2026, 10:55 UTC
  • 3
  • 1 comments

Bowman Secures Significant Mining-Related Awards

Market reaction Comment Full text

SIGNET JEWELERS LTD (SIG)

  • Business News
  • June 02, 2026, 10:50 UTC
  • 3
  • 1 comments

Signet Jewelers Reports First Quarter Fiscal 2027 Results

Market reaction Comment Full text

BUCKLE INC (BKE)

  • Business News
  • June 02, 2026, 10:50 UTC
  • 3
  • 1 comments

The Buckle, Inc. Reports Quarterly Dividend

Market reaction Comment Full text

DOLLAR GENERAL CORP (DG)

  • Business News
  • June 02, 2026, 10:50 UTC
  • 3
  • 1 comments

Dollar General Corporation Reports First Quarter 2026 Results

Market reaction Comment Full text

Merck & Company Inc (MRK)

  • Business News
  • June 02, 2026, 10:46 UTC
  • 3
  • 1 comments

Merck to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Market reaction Comment Full text

CITI TRENDS INC (CTRN)

  • Business News
  • June 02, 2026, 10:45 UTC
  • 3
  • 1 comments

CITITRENDS Announces First Quarter Fiscal 2026 Results

Market reaction Comment Full text

MERCK & CO., INC. (MRK)

  • Business News
  • June 02, 2026, 10:45 UTC
  • 3
  • 1 comments

Merck to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Market reaction Comment Full text

SELECT MEDICAL HOLDINGS CORP (SEM)

  • Business News
  • June 02, 2026, 10:45 UTC
  • 3
  • 1 comments

SEM Stock Notification: Select Medical Board Investigated for Breaching its Duties to Investors Over $16.50 Acquisition Price

Market reaction Comment Full text
  • Previous
  • 1739
  • 1740
  • 1741
  • 1742
  • 1743
  • Next

Search

News categories

  • Technical Exchange News(13595)
  • Event(6229)
  • SEC News(354872)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(194882)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin